$9.22B in 3Q HCA revenue, AmSurg stock report, New SurgCenter Development ASC & more – 5 recent ASC company key notes

Here are five recent news update on ambulatory surgery center companies.

Advertisement

Zacks has rated AmSurg stock at its highest ranking, “strong buy,” according to a NASDAQ report.

Hospital Corporation of America posted revenues of $9.22 billion in the third quarter of 2014, up 9 percent from the same period last year.

Richard L. Sharff, general counsel of Surgical Care Affiliates, sold 10,051 shares of SCA stock for a total transaction price of $305,449.89, according to a WKRB News & Analysis report.

SurgCenter Development and a group of physicians plan to develop a surgery center at University Estates in Athens, Ohio, according to an AthensOhioToday report.

Tenet Healthcare stock traded at $58.22 per share during the week of Oct. 20 to Oct. 24, up 2.9 percent.

If you have a question, issue or note to suggest on an ASC management and development company please contact Carrie Pallardy at cpallardy@beckershealthcare.com or Laura Dyrda at ldyrda@beckershealthcare.com.

More articles on ASC issues:
CMS delays review of lower GI/endoscopy codes
Price transparency could lower healthcare costs by 14%
7 things for ASC leaders to know for Monday

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC News

Advertisement

Comments are closed.